Sutro Biopharma Inc (STRO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | 4.914 | -35.781 | -26.765 | -29.377 | -11.673 | -28.698 | -31.858 | -24.335 |
| Return on Equity (%) | -3.745 | 19.698 | -313.4 | -48.615 | -14.949 | -36.105 | -50.767 | -58.246 |
| Return on Invested Capital (%) | -2.972 | 19.086 | -255.512 | -48.704 | -32.146 | -35.788 | -63.457 | -60.284 |
| Operating Margin (%) | 2.849 | -36.868 | -87.701 | -120.259 | -65.659 | -165.483 | -167.264 | -50.361 |
| Net Profit Margin (%) | 2.849 | -38.051 | -91.926 | -130.438 | -75.202 | -170.553 | -175.89 | -69.467 |
| Book Value Per Share | -201.108 | -234.411 | 5.757 | 4.233 | 7.258 | 5.452 | 3.775 | 2.455 |
| Earnings Per Share | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.073 | -1.752 |
| Cash Per Share | 25.648 | 47.355 | 5.484 | 0.215 | 4.506 | 0.657 | 0.822 | 1.136 |
| Working Capital Per Share | -1.091 | -13.606 | 7.595 | 4.139 | 7.619 | 3.816 | 4.984 | 5.378 |
| Operating Profit Per Share | 132.148 | 111.271 | 1.682 | 1.85 | 0.934 | 1.336 | 1.179 | 2.522 |
| EBIT Per Share | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.03 | -1.454 |
| EBITDA Per Share | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.03 | -1.454 |
| Free Cash Flow Per Share | 0.96 | -45.94 | -1.676 | -2.469 | -0.64 | -2.052 | -2.035 | -1.793 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 452k | 465k | 22.85M | 23.1M | 45.75M | 46.33M | 57.5M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 57.5M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -368.226 | N/A | N/A | N/A | -430.504 | N/A | N/A |
| Net Profit Margin (%) | N/A | -394.903 | N/A | N/A | N/A | -447.517 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 167.39M |
| Price to Earnings Ratio | -1.57 |
| Price to Sales Ratio | 1.09 |
| Price to Cash Ratio | 2.42 |
| Price to Book Ratio | 1.12 |
| Dividend Yield | - |
| Shares Outstanding | 82.46M |
| Average Volume (1 week) | 974.1k |
| Average Volume (1 Month) | 862.28k |
| 52 Week Change | -57.59% |
| 52 Week High | 6.13 |
| 52 Week Low | 1.67 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
